Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IART -1.49 to 21.68, getting what it deserves. It's a disgrace that the company has still not addressed quality control problems that were identified by the FDA last June. The warning letter that they just received represents an escalation by the FDA because the company has not acted on the form 483 notifications last summer. Management should be ousted.
RHE +2.02 to 3.57, after having hit 6.80 this morning, breaking down nicely .... I'm still short at 4.97 average. Surprised no interest from the board in shorting this one.
NMRA +.37 to 2.54, continuing to rebound nicely ....
fly -
Neumora Therapeutics price target lowered to $7 from $22 at BofA
BofA analyst Geoff Meacham lowered the firm's price target on Neumora Therapeutics to $7 from $22 and keeps a Buy rating on the shares. The firm notes Neumora reported that KOSTAL-1, one of three phase 3 trials, failed to show that navacaprant yielded a consistent benefit in depressed patients, noting an imbalance in results between males/females. Shares were down about 80% on that day, a level of decline suggesting there is no path forward. But theoretically, at least, there still is, if the two remaining trials, KOSTAL-2 and -3, are positive, BofA argues. With that said, the firm is lowering its probability of success from 65% to 30%, which lowers its sales and EPS forecasts beginning 2026.
OPTT +.15 to 1.26, has gone through the roof. I would have been much better off if I hadn't sold all those $0.50 covered calls. Nonetheless a nice winner for me.
RHE +3.55 to 5.10, a 230% gain in premarket on merger news .... at quick glance looks like both companies are unprofitable and this rally is overdone. I shorted a few shares at IB, but the stock is now a momentum play and could run higher before it corrects -
https://finance.yahoo.com/news/regional-health-properties-sunlink-health-122300226.html
Thanks, SSK - it's always interesting to see the stock picks.
That 9 digit code for PSIX is the CUSIP number. Evidently it changed for the uplisting or Schwab has not properly linked it in their database even though there was no symbol change.
As Bobkubecka reported you can trade PSIX on Think or Swim.
NMRA - analyst commentary from Mizuho this morning -
Neumora Therapeutics shares look oversold after Thursday's 81%
plunge on the heels of a failed Phase 3 study of the biotech's experimental
depression drug, Mizuho says. In a research note, analyst Graig Suvannavejh
says Neumora now trades at a negative enterprise value despite having a cash
runway to mid-2026 and other pipeline programs. Mizuho also notes that
Neumora still has two more navacaprant Phase 3 studies ongoing, and that
many antidepressants have had at least one Phase 3 failure before winning
approval. Neumora up 4.5% premarket to $2.06. (colin.kellaher@wsj.com)
NMRA +.35 to 2.32, rebounding nicely this morning. Wish I had bought a lot more shares yesterday. They bottomed at $1.69 in pre-market.
NMRA -8.63 to 1.97, I also added shares today and hedged with nice premiums on covered calls. Can't go too wrong at this price level. I think it will rebound in the coming weeks.
fly -
H.C. Wainwright still sees opportunity for Neumora despite trial miss
H.C. Wainwright says that while Neumora Therapeutics' KOASTAL-1 result "was a surprise and disappointment," the better results for female patients provide reason to remain confident in the drug's mechanism and pharmacology. This gives H.C. Wainwright "some optimism" the company will see a better outcome in the ongoing KOASTAL-2 and KOASTAL-3 studies, the analyst tells investors in a research note. The firm says the much better results for female patients is not that surprising because differences in response to major depressive disorder treatments across gender have been reported in many studies. Women are twice as likely as men to suffer from major depressive disorder and are more commonly treated with antidepressants, H.C. Wainwright contends. It is not clear whether the FDA would be willing to consider approval in female patients alone, but if the drug does have a differential effect in women, then the market opportunity would be reduced only modestly, the firm adds. It reiterates a Buy rating on the shares with a $30 price target. The stock in midday trading is down 81%, or $8.60, to $2.00.
Market Index Returns for 2024 -
TKR % Change Cur Price Start Price
$NYFANG 51% 13120.21 8716.33
$RLG 32% 4042.28 3051.68
$COMP 29% 19310.79 15011.35
$NDX 25% 21012.17 16825.93
$SPX 23% 5881.63 4769.83
$W5KMICRO15% 15415.18 13358.71
$DJI 13% 42544.22 37689.54
$MID 12% 3120.94 2781.54
$RUMIC 12% 820.06 731.01
$RLV 12% 1823.95 1629.42
$DJU 11% 982.74 881.67
$SPXEW 11% 7100.83 6402.89
$RUT 10% 2230.16 2027.07
$SML 7% 1408.17 1318.26
$DJT 0% 15895.75 15898.85
S&P500 goes from up 0.9% to down 0.6% .... maybe we're finally going to get a healthy 10% correction for this overbought market ?
briefing -
Midday Stock Market Summary
The stock market has exhibited choppy action at the index level on the first session of the year. The S&P 500, which traded up as much as 0.9%, sports a 0.6% decline in recent trading. The Nasdaq Composite shows a 0.7% decline after trading up as much as 1.1% at its intraday high.
Initial upside moves were related to buy-the-dip interest after a soft finish to the year. Some rebalancing activity and new inflows to start the month, quarter, and year also contributed to the positive bias. Market breadth is still positive despite index deterioration. Advancers lead decliners by a 4-to-3 margin at the NYSE and at the Nasdaq.
The major indices declined as mega caps turned lower and Treasury yields turned higher. The 10-yr yield, which hit 4.51% earlier, sits at 4.8%. The 2-yr yield, which hit 4.20% earlier, sits at 4.25%.
Microsoft (MSFT 415.92, -5.58, -1.3%), Amazon.com (AMZN 219.25, -0.15, -0.1%), and Alphabet (GOOG 189.73, -0.72, -0.4%) moved into negative territory, and Apple (AAPL 242.74, -7.65, -3.1%) and Tesla (TSLA 376.09, -27.73, -6.7%) extended initial declines, as the major equity indices fell.
The ongoing strength in the dollar, which can be a drag on earnings for multinational companies, has also contributed to downside moves in stocks. The U.S. Dollar Index is up 0.8% to 109.30 as the euro keeps sinking (EUR/USD -0.9% to 1.0264) on growth and policy rate divergences.
Reviewing today's economic data:
Initial jobless claims for the week ending December 28 decreased by 9,000 to 211,000 (Briefing.com consensus 224,000) while continuing jobless claims for the week ending December 21 decreased by 52,000 to 1.844 million.
The key takeaway from the report is the low level of initial claims -- a leading indicator -- as that connotes a situation where employers are reluctant to let employees go, which goes hand-in-hand with an optimistic view of business prospects.
Total construction spending was unchanged month-over-month in November (Briefing.com consensus 0.2%) following an upwardly revised 0.5% increase (from 0.4%) in October. Total private construction was up 0.1% month-over-month while total public construction declined 0.1% month-over-month. On a year-over-year basis, total construction spending was up 3.0%.
The key takeaway from the report is that there wasn't much impulse for construction spending in November, particularly on the nonresidential side of things.
December S&P Global US Manufacturing PMI - Final checked in at 49.4 versus the preliminary reading of 48.3 and the final November reading of 49.7. The dividing line between expansion and contraction is 50.0, so the December PMI represents activity contracting at a slightly faster pace than the prior month.
The MBA Mortgage Applications Index was down 21.9% from two weeks before with refinance applications down 36% and purchase applications down 13% (note: this data is usually released on a weekly basis, so the actuals, which aren't necessarily good, also aren't as bad as they appear at first blush)
The Magnificent 7 returned 60% on average for 2024 .... I think 2025 will bring far more modest returns for the group -
TKR % Change Cur Price Start Price
NVDA 171% 134.29 49.52
META 65% 585.51 353.96
TSLA 63% 403.84 248.48
AMZN 44% 219.39 151.94
GOOG 35% 190.44 140.93
AAPL 30% 250.42 192.53
MSFT 12% 421.5 376.04
AVERAGE RETURN = 60%
NMRA - true, but they have other trials underway. The selloff may be overdone.
NMRA -8.80 to 1.80 after reporting disappointing phase 3 anti-depressant drug trial results. Now it's a biobust. The stock action is rather depressing, to say the least.
PR -
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placebo
AES - ok thanks, the dollar has been very strong in recent months, but based on the earnings presentation it seems they are well hedged against currency risk.
SSK - AES - are you at all concerned that 2/3 of revenues come from 3rd world nations mostly in Latin America, especially Chile, Dominican Republic and El Salvador. Outside Latin America they also have significant revenue from Vietnam and Bulgaria (see 10K pg 171). So there's some risk in that including exchange rates. The strong dollar will hurt, although they do some hedging.
I own some AES, but fully hedged with covered calls which offer decent premiums when considering it's a utility.
Rebalancing could be bad for stocks. In many cases rebalancing means getting the stocks to bonds portfolio ratio back on target. After a great year for the market which caused stocks to get overweight in portfolios it means selling stocks to buy bonds. Not good for stocks ! I think 2025 could be a down year for the market. We shall see.
Moomoo and Webull are both Chinese owned. I definitely wouldn't want much of my brokerage assets with either of them, but I'm fine with 1% or 2%, just for the 4am trading, if it turns out to be profitable for me. For now I'll be using IB, but their commissions are significant, whereas Moomoo and Webull are free.
My primary account is Schwab, formerly Ameritrade, but I have several secondary accounts including IB. If I open a Webull account it will be tiny to start.
IDR -.12 to 9.92, has gotten beat up lately and tax loss selling is adding to the downward pressure. Those option premiums are decent. I put it on my watchlist, thanks.
I just temporarily switched my IB setting from Lite to Pro so I can trade from 4am to 7am, but the commissions can be significant, so I might try Webull or Moomoo -
https://portal.interactivebrokers.com/en/pricing/commissions-stocks.php
Are you doing any premarket trading before 7am ? Very few brokers offer the 4am to 7am trading window.
The Santa Clause Rally is not looking good at this point, which brings to mind this worrisome market adage -
If Santa Clause should fail to call, Bears may come to Broad and Wall.
Have you ever done any early pre-market trading ? I checked at 6:42am this morning and NXU was up 122% .... it's now up 495% on volume of 388M. Crazy action. Seems like stocks that are surging starting at 4am ultimately go much higher on average.
I'm thinking about opening an account at Webull or Moomoo to get in on some of the early action if I happen to be awake.
OPTT +.18 to .66, nice action, but who knows where it will be on the option expiration dates .... all my shares are hedged with $0.50 strike covered calls, but that's gotten my cost basis way down to around $0.18.
Lots of energy stocks have gotten beat up the past 6 weeks and may be oversold with crude oil stabilizing at around $70/bbl and NatGas surging recently as inventories dwindle and LNG exports trend steadily higher ....
SD looks like an interesting play on surging NG prices.
REI, BRY, VTLE
Thanks for mentioning CMCSA. I'm also interested in a few on the list aside from the six that I already own .... btw, I bought AES and WU based on your posts, so thanks.
Schwab might eventually offer 4am trading, but I don't think it will happen soon. After all, Interactive Brokers has been offering it for years and that hasn't swayed any of the other big online brokers to do likewise. Probably not much demand.
I think the 24 hour trading will always be restricted to very liquid stocks. There'd be near zero overnight volume in all the rest with potentially huge bid/ask spreads.
77 Candidates for a January bounce .... all have forward PE's of under 10 and are trading within 5% of 52wk lows and have been impacted by year end tax loss selling - I currently own AES, FOR, KOP, WU, COLL and PANL. SSKMP owns AES and WU.
Sym Price Fwd PE RSI Industry Company Name
OMC 86.49 9.9 27 Advertising Agencies Omnicom Group Inc
MOS 23.87 9.5 36 Agricultural Inputs Mosaic Company
AEO 16.46 9 37 Apparel Retail American Eagle Outfitters Inc
CSWC 21.58 8.8 37 Asset Management Capital Southwest Corp
GSBD 12.79 7.1 45 Asset Management Goldman Sachs BDC Inc
OCSL 15.26 6.9 38 Asset Management Oaktree Specialty Lending Corp
OFS 7.94 8.2 37 Asset Management OFS Capital Corp
ICMB 3.05 7.6 39 Asset Management Investcorp Credit Management BDC Inc
PSBD 15.51 8.5 42 Asset Management Palmer Square Capital BDC Inc
PSEC 4.26 8.5 38 Asset Management Prospect Capital Corp
OXSQ 2.46 9.8 27 Asset Management Oxford Square Capital Corp
WHF 9.75 6.7 30 Asset Management WhiteHorse Finance Inc
LEA 95.36 7.1 44 Auto Parts Lear Corp
MBIN 36.34 6.8 36 Banks - Regional Merchants Bancorp
JELD 8.21 8.3 21 Building Products & Equipment JELD-WEN Holding Inc
CE 68.76 7.4 33 Chemicals Celanese Corp
ECC 8.82 6.7 36 Closed-End Fund - Debt Eagle Point Credit Company Inc
PTMN 16.43 5.9 36 Closed-End Fund - Debt Portman Ridge Finance Corp
OXLC 5.11 7.4 40 Closed-End Fund - Debt Oxford Lane Capital Corp
GPRO 1.11 8.1 39 Consumer Electronics GoPro Inc
WU 10.68 5.9 44 Credit Services Western Union Company
BIIB 151.31 9.1 39 Drug Manufacturers - General Biogen Inc
AMPH 37.80 8.9 23 Drug Manufacturers - Specialty & Gen Amphastar Pharmaceuticals Inc
ANIP 54.41 10 43 Drug Manufacturers - Specialty & Gen ANI Pharmaceuticals Inc
COLL 29.11 4.4 39 Drug Manufacturers - Specialty & Gen Collegium Pharmaceutical Inc
OSK 94.35 8.9 30 Farm & Heavy Construction Machinery Oshkosh Corp
TEX 45.23 8.4 28 Farm & Heavy Construction Machinery Terex Corp
HY 50.17 9.3 34 Farm & Heavy Construction Machinery Hyster Yale Inc
BG 78.07 8.7 29 Farm Products Bunge Global SA
SPTN 18.21 9.2 35 Food Distribution SpartanNash Co
LEG 9.56 8.1 24 Furnishings Fixtures & Appliances Leggett & Platt Inc
HOFT 13.41 9.3 29 Furnishings Fixtures & Appliances Hooker Furnishings Corporation
CVS 44.49 7.3 29 Healthcare Plans CVS Health Corp
HVT 22.11 10 42 Home Improvement Retail Haverty Furniture Cos. Inc
EPC 34.10 9.7 39 Household & Personal Products Edgewell Personal Care Co
SSTK 30.26 6.5 42 Internet Content & Information Shutterstock Inc
PANL 4.89 6.4 29 Marine Shipping Pangaea Logistics Solutions Ltd
GNK 13.91 8.4 29 Marine Shipping Genco Shipping & Trading Limited
PACS 13.01 7.3 23 Medical Care Facilities PACS Group Inc
AVNS 15.92 9.4 27 Medical Devices Avanos Medical Inc
GHI 10.67 5.9 39 Mortgage Finance Greystone Housing Impact Investors LP
HP 30.76 8.5 34 Oil & Gas Drilling Helmerich & Payne Inc
NE 29.65 9.9 36 Oil & Gas Drilling Noble Corp Plc
OVV 38.68 8.6 36 Oil & Gas E&P Ovintiv Inc
MUR 28.66 8.6 32 Oil & Gas E&P Murphy Oil Corp
REI 1.25 3.1 33 Oil & Gas E&P Ring Energy Inc
SD 10.76 5.2 41 Oil & Gas E&P Sandridge Energy Inc
DVN 31.20 6.9 25 Oil & Gas E&P Devon Energy Corp
BRY 3.87 8.3 39 Oil & Gas E&P Berry Corp
BSM 14.15 9.8 37 Oil & Gas E&P Black Stone Minerals L.P
CHRD 112.07 8.8 33 Oil & Gas E&P Chord Energy Corp
CIVI 43.67 5 33 Oil & Gas E&P Civitas Resources Inc
NOV 14.47 9.4 38 Oil & Gas Equipment & Services NOV Inc
WFRD 68.58 9.7 31 Oil & Gas Equipment & Services Weatherford International plc
SUN 51.44 6.8 41 Oil & Gas Refining & Marketing Sunoco LP
OI 10.30 7 30 Packaging & Containers O-I Glass Inc
SON 48.89 8.7 36 Packaging & Containers Sonoco Products Co
FOR 25.70 6 28 Real Estate - Development Forestar Group Inc
HOG 30.28 7.5 33 Recreational Vehicles Harley-Davidson Inc
GIPR 1.79 1.5 44 REIT - Diversified Generation Income Properties Inc
CMTG 4.09 9.3 24 REIT - Mortgage Claros Mortgage Trust Inc
AGNC 9.33 5.5 39 REIT - Mortgage AGNC Investment Corp
AOMR 9.24 7 44 REIT - Mortgage Angel Oak Mortgage REIT Inc
STWD 19.30 9.7 40 REIT - Mortgage Starwood Property Trust Inc
TWO 11.74 6.5 47 REIT - Mortgage Two Harbors Investment Corp
MFA 10.43 6.4 35 REIT - Mortgage MFA Financial Inc
LEN 137.19 8.6 20 Residential Construction Lennar Corp
MTH 154.10 7.2 29 Residential Construction Meritage Homes Corp
DFH 23.19 7.1 24 Residential Construction Dream Finders Homes Inc
ARCO 7.29 9.4 32 Restaurants Arcos Dorados Holdings Inc
ST 27.38 8.1 27 Scientific & Technical Instruments Sensata Technologies Holding Plc
KOP 31.94 7.4 34 Specialty Chemicals Koppers Holdings Inc
ONEW 17.74 6.5 35 Specialty Retail Onewater Marine Inc
KELYA 13.18 5.3 32 Staffing & Employment Services Kelly Services Inc
CMCSA 37.93 8.6 34 Telecom Services Comcast Corp
BTU 19.96 7.5 24 Thermal Coal Peabody Energy Corp
AES 12.75 6.2 39 Utilities - Diversified AES Corp
Robinhood only offers trading starting at 7am, whereas Webull and Moomoo start at 4am. Reviews for Webull are generally positive from what I've read, but it has critics as well. Moomoo is less well known. One could try both to form one's own opinion. You're right about the 4am start though .... I'd much rather be asleep, unless the trading opportunities are so amazing that it's worthwhile to occasionally get up at that hour.
I did see some stocks recently that surged 30% to 50% higher in the 4am hour and became 100%+ gainers after 7am. But of course it's a double edged sword and there'd be losers as well. One would have to try it and judge by overall results.
Moomoo Brokerage offers 4am to 8pm trading without any special fees ..... also no commissions on stock options and low margin borrowing rates. I might open a trial account.
https://www.moomoo.com/community/feed/103174575357957
https://www.moomoo.com/us/pricing?global_content=%7B%22promote_id%22%3A13764%2C%22sub_promote_id%22%3A1%7D
I think all your stock picks were very liquid, albeit volatile, so the 15% rule should not apply. Stocks do legitimately gap up on strong volume without any obvious news. It could be due to volatility, a newsletter recommendation, pending analyst upgrade or a myriad of other reasons. If the gap up occurs in a highly illiquid stock due simply to a very wide bid/ask spread, then it relevant.
SSK will have the final say, but that's my interpretation of the 15% rule. It pertains to highly illiquid securities and not those that are simply experiencing volatility on heavy volume.
PDYN +5.40 to 12.69, up an amazing 207% since your post on Tuesday ! Congratulations. Regrettably I'm on the sidelines.
NMRA -.15 to 11.19 ahead of phase 3 results in the coming days. Phase 2 was positive and even if phase 3 disappoints, they have other drug trials underway. Stock is already way down from the 52wk high of $21.
I bought shares at $11.10 and sold the Jan 12.5 Calls for 4.50, giving me a low cost basis of $6.60. The call premiums are HUGE ahead of the phase 3 results due out any day.
https://seekingalpha.com/article/4746285-neumora-koastal-1-readout-for-mdd-treatment-is-first-study-on-deck
YTD Index Performance - note the big lag of the SPXEW versus SPX. The Mag7 propelled the S&P500 outperformance.
TKR % Change Cur Price Start Price
$NYFANG 57% 13662.94 8716.33
$RLG 37% 4189.22 3051.68
$COMP 33% 20020.36 15011.35
$NDX 29% 21768.31 16825.93
$SPX 27% 6037.59 4769.83
$W5KMICRO18% 15827.31 13358.71
$RUMIC 15% 842.33 731.01
$DJI 15% 43325.8 37689.54
$MID 14% 3168.15 2781.54
$RLV 14% 1850.32 1629.42
$SPXEW 13% 7213.51 6402.89
$RUT 12% 2280.19 2027.07
$DJU 12% 991.77 881.67
$SML 9% 1435.7 1318.26
$DJT 1% 16104.12 15898.85
AVERAGE RETURN = 20%
AIRE hit $4.49, a spectacular 230% gain from your timely alert on Tuesday ! Congrats on the quick and huge profits.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175575623&txt2find=aire
Congrats on AIRE .... great call on Tuesday. Are you taking any profits ???
OPTT +.11 to .44, nice call .... all my shares are hedged with covered calls, $0.50 strike, Jan, Feb and May .... I rolled over the expired Dec calls to May .... my cost basis on the stock is now .187 and dropping with every rollover. The option premiums are huge !
PSIX -1.50 to 31.09, after briefly hitting the $24's .... looks like some large holder dumped shares and triggered a cascade of stop loss sales. Anyone who bought in the $24's after seeing the stock stabilize has done extremely well.
Thanks for the link to the import data ..... very interesting, but is there any explanation for the nearly 2 year derth of imports prior to August ? Might that simply be bad data ?